Bristol Myers Squibb positions India as a growth engine, investing in AI-led pharma commercialization, pipeline expansion, and faster market adoption across oncology and cardiology.
.jpeg "Strides Pharma Slips After USFDA Issues Four Observations")
Strides Pharma shares dip after USFDA issues Form 483 observations at its US facility, though the company says issues are procedural with no supply impact.
Ajanta Pharma partners with Biocon to launch Semaglutide in emerging markets, boosting GLP-1 therapy access, therapeutic leadership, and commercial growth in diabetes care.
Industry leaders share how AI, GCCs, local manufacturing, and quality-first strategies are reshaping India’s life sciences, biometrics, medical devices, and lab solutions ecosystem.
India pharma partnerships in 2025 are accelerating innovation, patient care, digital transformation, and market leadership through strategic alliances across R&D, tech, and supply chains.
In 2025, India’s pharmaceutical sector is demonstrating remarkable dynamism, driven by a blend of global collaborations and homegrown innovation.
In 2025, India’s pharmaceutical sector is demonstrating remarkable dynamism, driven by a blend of global collaborations and homegrown innovation.
India strengthens pharma regulation in 2025 with WHO benchmarking, ONDLS solvent tracking, QR codes on critical drugs, and anti-dumping probes to boost safety and compliance.
Cipla has launched Afrezza, a rapid-acting inhalable insulin, marking a new addition to diabetes treatment options in India. The product offers a needle-free alternative to injectable mealtime insulin and is aimed at improving ease of use and trea...
Emcure Pharmaceuticals has announced a nationwide rollout of its obesity drug Poviztra, marking a focused push into India’s expanding weight-management market. The company plans to move beyond a metro-centric strategy and build demand across Tie...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")